AR051390A1 - Derivados de azetidina, pro - Google Patents

Derivados de azetidina, pro

Info

Publication number
AR051390A1
AR051390A1 ARP050104296A ARP050104296A AR051390A1 AR 051390 A1 AR051390 A1 AR 051390A1 AR P050104296 A ARP050104296 A AR P050104296A AR P050104296 A ARP050104296 A AR P050104296A AR 051390 A1 AR051390 A1 AR 051390A1
Authority
AR
Argentina
Prior art keywords
derivatives
azetidina
pro
methylsulfonamide
azetidin
Prior art date
Application number
ARP050104296A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR051390A1 publication Critical patent/AR051390A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento de preparacion e derivados de azetidina como el N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-quinol-6-il-metilsulfonamida y de su clorhidrato y del N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-(3,5-difluorofenil)- metilsulfonamida.
ARP050104296A 2004-10-14 2005-10-13 Derivados de azetidina, pro AR051390A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
AR051390A1 true AR051390A1 (es) 2007-01-10

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104296A AR051390A1 (es) 2004-10-14 2005-10-13 Derivados de azetidina, pro

Country Status (21)

Country Link
US (1) US7687493B2 (es)
EP (1) EP1805167A2 (es)
JP (1) JP2008516932A (es)
KR (1) KR20070063544A (es)
CN (1) CN101039931A (es)
AR (1) AR051390A1 (es)
AU (1) AU2005293454A1 (es)
BR (1) BRPI0516507A (es)
CA (1) CA2583992A1 (es)
EA (1) EA011408B1 (es)
EC (1) ECSP077332A (es)
FR (1) FR2876688B1 (es)
IL (1) IL181904A0 (es)
MA (1) MA29513B1 (es)
MX (1) MX2007003923A (es)
NO (1) NO20072192L (es)
SG (1) SG155193A1 (es)
TN (1) TNSN07097A1 (es)
TW (1) TW200630358A (es)
WO (1) WO2006040465A2 (es)
ZA (1) ZA200702528B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
JP4101053B2 (ja) * 2000-08-10 2008-06-11 田辺三菱製薬株式会社 プロリン誘導体及びその医薬用途
US7825109B2 (en) * 2003-08-29 2010-11-02 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof

Also Published As

Publication number Publication date
FR2876688A1 (fr) 2006-04-21
KR20070063544A (ko) 2007-06-19
BRPI0516507A (pt) 2008-09-16
TNSN07097A1 (fr) 2008-06-02
US20070270463A1 (en) 2007-11-22
MA29513B1 (fr) 2008-06-02
NO20072192L (no) 2007-04-27
MX2007003923A (es) 2007-06-07
TW200630358A (en) 2006-09-01
EA011408B1 (ru) 2009-02-27
WO2006040465A3 (fr) 2006-08-10
ZA200702528B (en) 2008-07-30
JP2008516932A (ja) 2008-05-22
IL181904A0 (en) 2007-07-04
ECSP077332A (es) 2007-04-26
EP1805167A2 (fr) 2007-07-11
FR2876688B1 (fr) 2007-03-16
CN101039931A (zh) 2007-09-19
US7687493B2 (en) 2010-03-30
WO2006040465A2 (fr) 2006-04-20
AU2005293454A1 (en) 2006-04-20
EA200700840A1 (ru) 2007-08-31
CA2583992A1 (fr) 2006-04-20
SG155193A1 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
GEP20125666B (en) HYDROXYMETHYL PYRROLIDINES AS β3 ADRENERGIC RECEPTOR AGONISTS
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
NZ596024A (en) Indole compounds
ATE537170T1 (de) Cgrp-rezeptorantagonisten
ATE469895T1 (de) Cgrp-rezeptorantagonisten
CR8481A (es) Derivados de triazol como antagonistas de la vasopresina
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
ATE500250T1 (de) Azetidinverbindungen als orexin-rezeptor- antagonisten
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
NO20081788L (no) Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
ATE411323T1 (de) Cgrp-rezeptorantagonisten
TW200734313A (en) Piperazines and piperidines as mGluR5 potentiators
PE20070490A1 (es) Compuestos derivados de bencimidazol-2-ona sustituidos con piperidina como agonistas del receptor muscarinico m1
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
RS50624B (sr) Monohidrohloridna so 1-[3-[3-(4-hlorofenil)propoksi]propil]piperidina
NO20084852L (no) MGLUR5 modulatorer V
NO20084007L (no) Spirokondenserte piperidiner som modulatorer av muskarinreseptorer
ATE444990T1 (de) Spritzbare akustikmassen
EA201070689A1 (ru) Композиция для личного ухода
DE602007013412D1 (de) Therapeutische amide und entsprechende verbindungen
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
ECSP088476A (es) Combinación de productos activos fungicidas
TW200740769A (en) Novel process

Legal Events

Date Code Title Description
FB Suspension of granting procedure